✦ LIBER ✦

Mapping the effects of the selective dopamine D2/D3 receptor agonist quinelorane using pharmacological magnetic resonance imaging

✍ Scribed by M.D. Ireland; A.S. Lowe; C. Reavill; M.F. James; R.A. Leslie; S.C.R. Williams

Book ID: 116786958
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 714 KB
Volume: 133
Category: Article
ISSN: 0306-4522
DOI: 10.1016/j.neuroscience.2005.02.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mapping dopamine D2/D3 receptor function

Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging

✍ Yin-Ching I. Chen; Ji-Kyung Choi; Susan L. Andersen; Bruce R. Rosen; Bruce G. Je 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 777 KB

Effects of D2 dopamine receptor agonist

Effects of D2 dopamine receptor agonist and antagonist on brain activity in the rat assessed by functional magnetic resonance imaging

✍ Hirofumi Hagino; Eiichi Tabuchi; Masayoshi Kurachi; Osamu Saitoh; Yueji Sun; Tak 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 294 KB

Autoradiographic localisation of D3-dopa

Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907

✍ H. Hall; C. Halldin; Durk Dijkstra; Håkan Wikström; Lawrence D. Wise; Thomas A. 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 781 KB

Dopamine D2 receptor knock-out mice are

Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists

✍ D Boulay; R Depoortere; Gh Perrault; E Borrelli; D.J Sanger 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Antiparkinsonian effects of the novel D3

Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors

✍ Michael P. Hill; Paula Ravenscroft; Steven G. McGuire; Jonathan M. Brotchie; Ala 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

L-dopa remains the most common treatment for Parkinson's disease. However, there is considerable interest in D3/D2 receptor agonists such as the novel agent S32504, since they exert antiparkinsonian properties in the absence of dyskinesia. An important question concerns the roles of D2 vs. D3 recept

Effects of the selective dopamine D-2 re

Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat

✍ Jaime M. Monti; Héctor Jantos; Mónica Fernández 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 414 KB